Cite

HARVARD Citation

    Kudo, K. et al. (2020). Divergent metabolic responses dictate vulnerability to NAMPT inhibition in ovarian cancer. FEBS letters. 594 (9), pp. 1379-1388. [Online]. 
  
Back to record